PharmaCorp to Acquire a Pharmacy in Ontario for $5,300,000, New Non-Binding Letter of Intent to Acquire Two Pharmacies in Eastern Canada, Updates on Previously Announced Non-Binding Letters of Intent and Filing of Q2 Investor Presentation

SASKATOON, Saskatchewan, Sept. 08, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce the signing of a definitive share purchase agreement to acquire a 100% interest in a PharmaChoice Canada bannered pharmacy business located in Ontario (the “Acquisition”). This transaction marks PharmaCorp’s first acquisition under its charter company structure, which was established through the purchase completed on April 30, 2025. In addition, PharmaCorp has entered into a non-binding letter of intent to acquire two pharmacies in Atlantic Canada (the “Atlantic Canada LOI”), is providing an update on the four transactions previously announced on May 29, 2025, and has filed its Q2 Investor Presentation.

Read more at globenewswire.com